Actualités

Autoantibodies against interferons, or why certain viruses affect us differently

Even our DNA can be recycled: the example of Cajal-Retzius cells

Launch of the Sharing Fund "Invest for Childhood": When private equity serves the common good

A new bifunctional gene therapy vector for sickle cell disease

MEDETIA, in partnership with Institut Imagine and Inserm Transfert, launches an innovative research program with Ipsen

Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector

Identification of a new mutation affecting the IRF4 gene associated with a primary immunodeficiency

The cytoplasmic protein RIPK3 influences the severity of viral encephalitis due to herpes by limiting the viral load

Discovery of DOCK11 mutations responsible for a new X-linked autoimmune disease

Identification of a new gene involved in severe allergies and eczema

Launch of a sponsorship partnership with BNP Paribas Cardif

Identification of a whole new type of mutation in immune deficiencie

Accelerating gene therapy: assessment and prospects at the end of the DIM Gene Therapy program

Training today for better care tomorrow

Covid-19: inborn errors responsible for multisystemic inflammatory syndrome in children